The Valley Desk

Clinical trial reportInternational journal of cancerPublished

Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
International journal of cancer
Published
Subject terms
Humans; Breast Neoplasms; Ovarian Neoplasms; Piperazines; Phthalazines; BRCA1 Protein; Germ-Line Mutation; Quality of Life; Female; Breast cancer; Subgroups; Olaparib
PubMed ID
36971103
Added to directory
Source checked

Report a correction or request removal